PF0 Stock Overview
Develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
NetraMark Holdings Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.34 |
52 Week High | CA$0.35 |
52 Week Low | CA$0.084 |
Beta | 0.64 |
11 Month Change | 100.00% |
3 Month Change | 205.45% |
1 Year Change | 41.18% |
33 Year Change | -68.30% |
5 Year Change | n/a |
Change since IPO | -80.18% |
Recent News & Updates
Recent updates
Shareholder Returns
PF0 | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | 50.0% | -1.3% | -0.4% |
1Y | 41.2% | -33.1% | 7.1% |
Return vs Industry: PF0 exceeded the German Healthcare Services industry which returned -32.3% over the past year.
Return vs Market: PF0 exceeded the German Market which returned 7.8% over the past year.
Price Volatility
PF0 volatility | |
---|---|
PF0 Average Weekly Movement | 23.6% |
Healthcare Services Industry Average Movement | 5.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PF0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PF0's weekly volatility has increased from 17% to 24% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | George Achilleos | www.netramark.com |
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023.
NetraMark Holdings Inc. Fundamentals Summary
PF0 fundamental statistics | |
---|---|
Market cap | €25.87m |
Earnings (TTM) | -€7.62m |
Revenue (TTM) | €234.14k |
108.4x
P/S Ratio-3.3x
P/E RatioIs PF0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PF0 income statement (TTM) | |
---|---|
Revenue | CA$345.02k |
Cost of Revenue | CA$0 |
Gross Profit | CA$345.02k |
Other Expenses | CA$11.57m |
Earnings | -CA$11.22m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.16 |
Gross Margin | 100.00% |
Net Profit Margin | -3,253.24% |
Debt/Equity Ratio | 0% |
How did PF0 perform over the long term?
See historical performance and comparison